2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for PFIZER

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade issues related to Trade Promotion Authority legislation.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
ERIN BOOK MULLEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; 21st Century Cures Initiative.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare payment issues including the Independent Payment Advisory Board (IPAB) and Medicaid issues. Medicare Part D. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. CMMI Medicare Part B Demonstration.

LobbyistCovered position, as disclosed
SHANE DOUCET —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
ANDREW JONES Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep Lujan
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2 (114th)

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry including international tax. Revenue proposals on international tax. Comprehensive tax reform proposals.

LobbyistCovered position, as disclosed
DENIS DWYER —
CHRISTOPHER W HATCHER —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.